CYduct Diagnostics, Inc. (CYDX)
OTCMKTS · Delayed Price · Currency is USD
0.4030
-0.2070 (-33.93%)
At close: May 21, 2026
CYduct Diagnostics Market Cap
CYduct Diagnostics has a market cap or net worth of $2.11 million as of June 18, 2026. Its market cap has decreased by -55.43% in one year.
Market Cap
2.11M
Enterprise Value
n/a
Revenue
344.78K
Ranking
n/a
PE Ratio
15.47
Stock Price
$0.40
Market Cap Chart
Since October 21, 2009, CYduct Diagnostics's market cap has decreased from 13.69M to 2.11M, a decrease of -84.57%. That is a compound annual growth rate of -10.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 2.11M | 164.96% |
| Dec 27, 2024 | 797.13K | -69.60% |
| Dec 11, 2023 | 2.62M | -49.00% |
| Dec 29, 2021 | 5.14M | 66.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ludwig Enterprises | 3.73M |
| QHSLab | 3.69M |
| Biotricity | 3.58M |
| Holdco Nuvo Group D.G | 3.33M |
| Sonendo | 2.87M |
| Lifeline Biotechnologies | 2.61M |
| St. Joseph | 1.91M |
| Vycor Medical | 1.90M |